XML 37 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
Unaudited Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
9 Months Ended
May 26, 2012
May 28, 2011
Operating activities:    
Net income $ 4,064 $ 8,296
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Depreciation and amortization 3,786 4,193
LIFO expense 844 1,193
Asset impairment 0 605
Stock-based compensation 863 1,001
Deferred income taxes including valuation (provision) allowance (753) 874
Postretirement benefit income and deferred compensation expenses 510 1,034
Provision for doubtful accounts 28 5
Increase in cash surrender value of life insurance policies (523) (617)
Loss (gain) on sale or disposal of property 20 (867)
Gain on life insurance (281) (372)
Other 579 90
Change in assets and liabilities:    
Inventories (1,283) (30,091)
Receivables and prepaid assets 1,893 2,609
Income taxes and unrecognized tax benefits 105 (747)
Accounts payable and accrued expenses 4,950 1,523
Postretirement and deferred compensation benefits (3,053) (2,792)
Net cash provided by (used in) operating activities 11,749 (14,063)
Investing activities:    
Proceeds from the sale of investments, at par 750 6,450
Proceeds from life insurance 1,404 659
Purchases of property and equipment (1,527) (1,590)
Proceeds from the sale of property 16 4,009
Cash paid for acquisition, net of cash acquired 0 (4,694)
Other (558) (410)
Net cash provided by investing activities 85 4,424
Financing activities:    
Payments for purchases of common stock (343) (89)
Proceeds from exercise of stock options 0 83
Other 33 184
Net cash (used in) provided by financing activities (310) 178
Net increase (decrease) in cash and cash equivalents 11,524 (9,461)
Cash and cash equivalents at beginning of period 69,307 74,691
Cash and cash equivalents at end of period 80,831  
Supplemental cash flow disclosure:    
Income taxes paid, net of refunds $ 115 $ 1,638